Corcept Therapeutics return on investment for the quarter ending December 31, 2024 was 86.82.
Corcept Therapeutics average return on investment for 2023 was 179.31, a 0% decline from 2022.
Corcept Therapeutics average return on investment for 2022 was 179.31, a 0% decline from 2021.
Corcept Therapeutics average return on investment for 2021 was 179.31, a 0% decline from 2020.
Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.